Teratogenicity of antibacterial agents

Collegium Antropologicum

Volumn 32, Issue 3, 2008, Pages 919-925

  Erić, Mirela ^a   Sabo, Ana ^a  

^a UNIVERSITY OF NOVI SAD   (Serbia)

Author keywords

Abnormalities; Adverse effects; Antibiotics; Fetus+drug effects; Pregnancy complications; Pregnancy+drug effects; Teratogens

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIINFECTIVE AGENT; BETA LACTAM; CEFALEXIN;

ADULT; ARTICLE; CONGENITAL MALFORMATION; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; HUMAN; LONGITUDINAL STUDY; NEWBORN; PREGNANCY; PREVALENCE; SERBIA;

ABNORMALITIES, DRUG-INDUCED; ADULT; AMOXICILLIN; AMPICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CEPHALEXIN; FEMALE; FETUS; HUMANS; INFANT, NEWBORN; LONGITUDINAL STUDIES; MATERNAL-FETAL EXCHANGE; PREGNANCY; PREVALENCE; SERBIA;

EID: 53549126969     PISSN: 03506134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. SABO A, STANULOVIĆ M, JAKOVUEVIĆ y GRUJIĆ Z, Pharmacoepidemiol Drug Saf, 10 (2001) 229.
2. MILJKOVIĆ Z, SABO A, STANULOVIĆ M, JAKOVUEVIĆ y GRUJIĆ I, Med Pregl, 44 (2001) 34.
3. O' GRADY F, LAMBERT HP, FINCH R, GREENWOOD D, Antibiotic and Chemotherapy, Antiinfective Agents and Their Use in Therapy (Churchill Livingstone, New York, 1997).
4. HARDMAN JG, LIMBIRD LE, GILMAN AG, The Pharmacological Basis of Therapeutics (The McGraw-Hill Companies, New York, 2001).
5. HEADLEY J, NORTHSTONE K, SIMMONS H, GOLDING J and the ALSPAC Study Team, Eur J Clin Pharmacol, 60 (2004) 355.
6. EGEN-LAPPE y HASFORD J, Eur J Clin Pharmacol, 60 (2004) 659.
7. DONATI S, BAGLIO G, SPINELLI A, GRANDOLFO EM, Eur J Clin Pharmacol, 56 (2000) 323.
8. THURMANN PA, STEIOFF A, Int J Clin Pharmacol Ther, 39 (2001) 185.
9. SHEPARD TH, Curr Probl Pediatr, 10 (1979) 1.
10. FREEDMAN MJ, POLIFKA EJ, The Effects of Drugs on the Fetus and Nursing Infant: A Handbook for Health Care Professionals (Johns Hopkins University Press, 1996).
11. KOREN G, Maternal-Fetal Toxicology, A Clinician's Guide (Marcel Dekker, New York, 2001).
12. FREEDMAN MJ, POLIFKA EJ, Teratogenic Effects of Drugs: A Resource for Clinician's (Johns Hopkins University Press, 2000).
13. LENZ WA, Symposium on embryopathy activity of drugs (Churchill, London, 1965).
14. BRIGGS GG, REEMAN RK, YAFFE SJ, Drugs in Pregnancy and lactation (Williams and Wilkins, Baltimore, 1998).
15. MALM H, MARTIKAINEN J, KLAURRA T, NEUVONEN JP, Eur J Clin Pharmacol, 59 (2003) 127.
16. BOJANIĆ ŽZ, Lekovi i trudnoća (Vojna štamparya, Beograd, 2001).
17. PROSTRAN M, Antibiotici 2001 (Zavod za udžbenike i nastavna sredstva, Beograd, 2001).
18. NATHANSON S, MOREAU E, MERLBT-BBNICHOU C, GILBERT T, J Am Soc Nephrol, 11 (2000) 874.
19. CARTER M, WILSON F, Lancet, 1 (1963) 1267.
20. CARTER M, WILSON F, Dev Med Child Neurol, 7 (1965) 353.
21. ZIERLER S, Obstet Gynecol, 65 (1985) 155.
22. ABOU-TARBOUSH FM, Arab Gulf Journal of Scientific Research, 12 (1994) 133.
23. JAKOBI R NEIGER R, MERZBACH D, PALDI E, Am J Obstet Gynecol, 156 (1987) 1148.
24. PFAU A, SACKS TG, Clin Infect Dis, 14 (1992) 810.
25. SABO A, TOMIĆ Z, STANULOVIĆ M, Antibakterijski lekovi (Savremena farmakoteraplja, Novi Sad-Podgorica, 2001).
26. ERIĆ M, Ispitivanje teratogenog efekta lekova na plod. MS Thesis. In Serbian (University in Novi Sad, Novi Sad, 2004). -27. STEWART DJ, Br J Dermatol, 76 (1964) 374.
27. INGALLS TH, PRINDLE RA, N Engl J Med, 240 (1949) 987.
28. HARLYJD, FARRARJF, GRAYJB, DUNLOPIC, Lancet, 1 (1964)472.
29. HEINONEN OP, SLONE D, SHAPIRO S, Birth defects and drugs in pregnancy (Publishing Sciences Group, Littleton, 1977).
30. KOREN G, PASTUSZAKA, ITO S, N Engl J Med, 338 (1998) 1128.
31. IRL K, HASFORD J, Drug Safety, 22 (2000) 169.
32. NORRBY SR, LIETMAN PS, Drugs, 45 (1933) 59.
33. SCHAEFER C, AMOURA-ELEFANT E, VIAL T, ORNOY A, GARBIS H, ROBERT E, RODRIGUEZ-PINILLA E, PEXIEDER T, PRAPAS N, MERLOB R Eur J Obstet Gynecol Reprod Biol, 69 (1996) 83.
34. AMERICAN HOSPITAL FORMULARY SERVICE, Drug Information 1997 (American Society of Health-System Pharmacists, Bethesda, 1997).